accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001628280-26-053791 | 1704292 | Zai Lab Ltd | ZLAB | 2026-08-06 | 8-K | fast_track | false | zlab-202686x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1704292/000162828026053791/zlab-202686x8kex991.htm |
0001628280-26-053791 | 1704292 | Zai Lab Ltd | ZLAB | 2026-08-06 | 8-K | orphan | false | zlab-202686x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1704292/000162828026053791/zlab-202686x8kex991.htm |
0001628280-26-053791 | 1704292 | Zai Lab Ltd | ZLAB | 2026-08-06 | 8-K | pdufa | false | zlab-202686x8kex991.htm | https://www.sec.gov/Archives/edgar/data/1704292/000162828026053791/zlab-202686x8kex991.htm |
0001345016-26-000059 | 1345016 | YELP INC | YELP | 2026-08-06 | 8-K | topline | false | yelpq22026ex992lettertos.htm | https://www.sec.gov/Archives/edgar/data/1345016/000134501626000059/yelpq22026ex992lettertos.htm |
0001193125-26-338019 | 1582313 | Xenon Pharmaceuticals Inc. | XENE | 2026-08-06 | 8-K | topline | false | xene-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1582313/000119312526338019/xene-ex99_1.htm |
0001640266-26-000007 | 1640266 | Voyager Therapeutics, Inc. | VYGR | 2026-08-06 | 8-K | ind | false | vygr-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1640266/000164026626000007/vygr-ex99_1.htm |
0001753926-26-001349 | 1266806 | Vivani Medical, Inc. | VANI | 2026-08-06 | 8-K | topline | false | ex991_1.htm | https://www.sec.gov/Archives/edgar/data/1266806/000175392626001349/ex991_1.htm |
0001628280-26-054341 | 1411685 | Vistagen Therapeutics, Inc. | VTGN | 2026-08-06 | 8-K | topline | false | vtgn-20260806.htm | https://www.sec.gov/Archives/edgar/data/1411685/000162828026054341/vtgn-20260806.htm |
0001193125-26-336691 | 1590750 | Viridian Therapeutics, Inc.\DE | VRDN | 2026-08-06 | 8-K | topline | false | d174744dex991.htm | https://www.sec.gov/Archives/edgar/data/1590750/000119312526336691/d174744dex991.htm |
0001193125-26-336691 | 1590750 | Viridian Therapeutics, Inc.\DE | VRDN | 2026-08-06 | 8-K | pdufa | false | d174744dex991.htm | https://www.sec.gov/Archives/edgar/data/1590750/000119312526336691/d174744dex991.htm |
0001792044-26-000037 | 1792044 | Viatris Inc | VTRS | 2026-08-06 | 8-K | topline | false | exhibit991-2q26earningsrel.htm | https://www.sec.gov/Archives/edgar/data/1792044/000179204426000037/exhibit991-2q26earningsrel.htm |
0001792044-26-000037 | 1792044 | Viatris Inc | VTRS | 2026-08-06 | 8-K | pdufa | false | exhibit991-2q26earningsrel.htm | https://www.sec.gov/Archives/edgar/data/1792044/000179204426000037/exhibit991-2q26earningsrel.htm |
0001193125-26-338273 | 1660334 | Verrica Pharmaceuticals Inc. | VRCA | 2026-08-06 | 8-K | topline | false | d13828dex991.htm | https://www.sec.gov/Archives/edgar/data/1660334/000119312526338273/d13828dex991.htm |
0001104659-26-092058 | 1526119 | Verastem, Inc. | VSTM | 2026-08-06 | 8-K | fast_track | false | tm2622452d2_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926092058/tm2622452d2_ex99-1.htm |
0001437749-26-026280 | 72444 | Vaxart, Inc. | VXRT | 2026-08-06 | 8-K | topline | false | ex_1000406.htm | https://www.sec.gov/Archives/edgar/data/72444/000143774926026280/ex_1000406.htm |
0001193125-26-337974 | 1563880 | Trevi Therapeutics, Inc. | TRVI | 2026-08-06 | 8-K | topline | false | trvi-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1563880/000119312526337974/trvi-ex99_1.htm |
0001193125-26-338000 | 1681087 | Tectonic Therapeutic, Inc. | TECX | 2026-08-06 | 8-K | topline | false | d114671dex991.htm | https://www.sec.gov/Archives/edgar/data/1681087/000119312526338000/d114671dex991.htm |
0001819790-26-000063 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-08-06 | 8-K | topline | false | exhibit991tarsus862026.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000063/exhibit991tarsus862026.htm |
0001819790-26-000060 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-08-06 | 8-K | topline | false | acquisitionannouncementf.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000060/acquisitionannouncementf.htm |
0001819790-26-000063 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-08-06 | 8-K | endpoint_met | false | exhibit991tarsus862026.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000063/exhibit991tarsus862026.htm |
0001819790-26-000062 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-08-06 | 8-K | clinical_hold | true | exhibit101_spa.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000062/exhibit101_spa.htm |
0001628280-26-053832 | 2036042 | Sionna Therapeutics, Inc. | SION | 2026-08-06 | 8-K | topline | false | sion2q26earningsrelease_fi.htm | https://www.sec.gov/Archives/edgar/data/2036042/000162828026053832/sion2q26earningsrelease_fi.htm |
0001193125-26-336715 | 1727196 | Scholar Rock Holding Corp | SRRK | 2026-08-06 | 8-K | topline | false | srrk-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1727196/000119312526336715/srrk-ex99_1.htm |
0001193125-26-336715 | 1727196 | Scholar Rock Holding Corp | SRRK | 2026-08-06 | 8-K | pdufa | false | srrk-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1727196/000119312526336715/srrk-ex99_1.htm |
0001635088-26-000088 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-08-06 | 8-K | topline | false | q1fy2026roivantearningsrel.htm | https://www.sec.gov/Archives/edgar/data/1635088/000163508826000088/q1fy2026roivantearningsrel.htm |
0001635088-26-000088 | 1635088 | Roivant Sciences Ltd. | ROIV | 2026-08-06 | 8-K | breakthrough | false | q1fy2026roivantearningsrel.htm | https://www.sec.gov/Archives/edgar/data/1635088/000163508826000088/q1fy2026roivantearningsrel.htm |
0001213900-26-086190 | 1553643 | RELMADA THERAPEUTICS, INC. | RLMD | 2026-08-06 | 8-K | topline | false | ea030099301ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1553643/000121390026086190/ea030099301ex99-1.htm |
0001213900-26-086190 | 1553643 | RELMADA THERAPEUTICS, INC. | RLMD | 2026-08-06 | 8-K | orphan | false | ea030099301ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1553643/000121390026086190/ea030099301ex99-2.htm |
0001213900-26-086190 | 1553643 | RELMADA THERAPEUTICS, INC. | RLMD | 2026-08-06 | 8-K | ind | false | ea030099301ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1553643/000121390026086190/ea030099301ex99-2.htm |
0001193125-26-336716 | 1590877 | REGENXBIO Inc. | RGNX | 2026-08-06 | 8-K | topline | false | rgnx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1590877/000119312526336716/rgnx-ex99_1.htm |
0001193125-26-336716 | 1590877 | REGENXBIO Inc. | RGNX | 2026-08-06 | 8-K | endpoint_met | false | rgnx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1590877/000119312526336716/rgnx-ex99_1.htm |
0001689548-26-000082 | 1689548 | Praxis Precision Medicines, Inc. | PRAX | 2026-08-06 | 8-K | topline | false | praxisq22026pr.htm | https://www.sec.gov/Archives/edgar/data/1689548/000168954826000082/praxisq22026pr.htm |
0001689548-26-000082 | 1689548 | Praxis Precision Medicines, Inc. | PRAX | 2026-08-06 | 8-K | endpoint_missed | true | praxisq22026pr.htm | https://www.sec.gov/Archives/edgar/data/1689548/000168954826000082/praxisq22026pr.htm |
0001689548-26-000082 | 1689548 | Praxis Precision Medicines, Inc. | PRAX | 2026-08-06 | 8-K | interim | false | praxiscorporatedeckaugus.htm | https://www.sec.gov/Archives/edgar/data/1689548/000168954826000082/praxiscorporatedeckaugus.htm |
0001689548-26-000082 | 1689548 | Praxis Precision Medicines, Inc. | PRAX | 2026-08-06 | 8-K | breakthrough | false | praxisq22026pr.htm | https://www.sec.gov/Archives/edgar/data/1689548/000168954826000082/praxisq22026pr.htm |
0001689548-26-000082 | 1689548 | Praxis Precision Medicines, Inc. | PRAX | 2026-08-06 | 8-K | orphan | false | praxisq22026pr.htm | https://www.sec.gov/Archives/edgar/data/1689548/000168954826000082/praxisq22026pr.htm |
0001689548-26-000082 | 1689548 | Praxis Precision Medicines, Inc. | PRAX | 2026-08-06 | 8-K | pdufa | false | praxisq22026pr.htm | https://www.sec.gov/Archives/edgar/data/1689548/000168954826000082/praxisq22026pr.htm |
0001193125-26-336767 | 1835597 | PepGen Inc. | PEPG | 2026-08-06 | 8-K | clinical_hold | true | pepg-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1835597/000119312526336767/pepg-ex99_2.htm |
0001193125-26-336767 | 1835597 | PepGen Inc. | PEPG | 2026-08-06 | 8-K | fast_track | false | pepg-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1835597/000119312526336767/pepg-ex99_2.htm |
0001559053-26-000021 | 1559053 | PROTHENA CORP PUBLIC LTD CO | PRTA | 2026-08-06 | 8-K | fast_track | false | exhibit991q22026earningsre.htm | https://www.sec.gov/Archives/edgar/data/1559053/000155905326000021/exhibit991q22026earningsre.htm |
0001628280-26-053836 | 1357874 | PRECISION BIOSCIENCES INC | DTIL | 2026-08-06 | 8-K | fast_track | false | q22026earningsrelease_final.htm | https://www.sec.gov/Archives/edgar/data/1357874/000162828026053836/q22026earningsrelease_final.htm |
0001628280-26-053836 | 1357874 | PRECISION BIOSCIENCES INC | DTIL | 2026-08-06 | 8-K | orphan | false | q22026earningsrelease_final.htm | https://www.sec.gov/Archives/edgar/data/1357874/000162828026053836/q22026earningsrelease_final.htm |
0001628280-26-053824 | 1228627 | Opus Genetics, Inc. | IRD | 2026-08-06 | 8-K | topline | false | ird-202686xex991.htm | https://www.sec.gov/Archives/edgar/data/1228627/000162828026053824/ird-202686xex991.htm |
0001846253-26-000044 | 1846253 | OmniAb, Inc. | null | 2026-08-06 | 8-K | topline | false | a2026q2ex991.htm | https://www.sec.gov/Archives/edgar/data/1846253/000184625326000044/a2026q2ex991.htm |
0001104659-26-091691 | 1372299 | Ocugen, Inc. | OCGN | 2026-08-06 | 8-K | topline | false | tm2622368d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926091691/tm2622368d1_ex99-1.htm |
0001000694-26-000019 | 1000694 | NOVAVAX INC | NVAX | 2026-08-06 | 8-K | fast_track | false | prfinal.htm | https://www.sec.gov/Archives/edgar/data/1000694/000100069426000019/prfinal.htm |
0001104659-26-091981 | 1638287 | MetaVia Inc. | MTVA | 2026-08-06 | 8-K | topline | false | mtva-20260806xex99d1.htm | https://www.sec.gov/Archives/edgar/data/1638287/000110465926091981/mtva-20260806xex99d1.htm |
0001628280-26-054330 | 1806952 | Lyell Immunopharma, Inc. | LYEL | 2026-08-06 | 8-K | fast_track | false | lyel-20260806x8kexx991.htm | https://www.sec.gov/Archives/edgar/data/1806952/000162828026054330/lyel-20260806x8kexx991.htm |
0001628280-26-054330 | 1806952 | Lyell Immunopharma, Inc. | LYEL | 2026-08-06 | 8-K | orphan | false | lyel-20260806x8kexx991.htm | https://www.sec.gov/Archives/edgar/data/1806952/000162828026054330/lyel-20260806x8kexx991.htm |
0001193125-26-336771 | 1521036 | Lantheus Holdings, Inc. | LNTH | 2026-08-06 | 8-K | crl | true | lnth-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1521036/000119312526336771/lnth-ex99_1.htm |
0000886163-26-000041 | 886163 | LIGAND PHARMACEUTICALS INC | null | 2026-08-06 | 8-K | topline | false | q22026earningsrelease_ex991.htm | https://www.sec.gov/Archives/edgar/data/886163/000088616326000041/q22026earningsrelease_ex991.htm |
0000886163-26-000041 | 886163 | LIGAND PHARMACEUTICALS INC | null | 2026-08-06 | 8-K | breakthrough | false | q22026earningsrelease_ex991.htm | https://www.sec.gov/Archives/edgar/data/886163/000088616326000041/q22026earningsrelease_ex991.htm |
0001062822-26-000112 | 1062822 | LEXICON PHARMACEUTICALS, INC. | LXRX | 2026-08-06 | 8-K | topline | false | pressreleaseearningsq208-0.htm | https://www.sec.gov/Archives/edgar/data/1062822/000106282226000112/pressreleaseearningsq208-0.htm |
0001193125-26-336685 | 1703647 | Korro Bio, Inc. | KRRO | 2026-08-06 | 8-K | orphan | false | krro-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1703647/000119312526336685/krro-ex99_1.htm |
0001193125-26-336772 | 1652130 | Intellia Therapeutics, Inc. | NTLA | 2026-08-06 | 8-K | topline | false | ntla-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1652130/000119312526336772/ntla-ex99_1.htm |
0001193125-26-336772 | 1652130 | Intellia Therapeutics, Inc. | NTLA | 2026-08-06 | 8-K | endpoint_met | false | ntla-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1652130/000119312526336772/ntla-ex99_1.htm |
0001764013-26-000100 | 1764013 | Immunovant, Inc. | IMVT | 2026-08-06 | 8-K | topline | false | exhibit991202686.htm | https://www.sec.gov/Archives/edgar/data/1764013/000176401326000100/exhibit991202686.htm |
0001671927-26-000020 | 1671927 | Immunocore Holdings plc | IMCR | 2026-08-06 | 8-K | topline | false | pressrelease-q22026.htm | https://www.sec.gov/Archives/edgar/data/1671927/000167192726000020/pressrelease-q22026.htm |
0001104659-26-091619 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-08-06 | 8-K | interim | false | tm2622322d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926091619/tm2622322d1_ex99-1.htm |
0001104659-26-092145 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-08-06 | 8-K | interim | false | tm2622463d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926092145/tm2622463d1_ex99-1.htm |
0001104659-26-092145 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-08-06 | 8-K | fast_track | false | tm2622463d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926092145/tm2622463d1_ex99-1.htm |
0001104659-26-091619 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-08-06 | 8-K | fast_track | false | tm2622322d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926091619/tm2622322d1_ex99-1.htm |
0001104659-26-092145 | 1425205 | IOVANCE BIOTHERAPEUTICS, INC. | IOVA | 2026-08-06 | 8-K | ind | false | tm2622463d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1425205/000110465926092145/tm2622463d1_ex99-1.htm |
0001140361-26-031502 | 1104506 | INSMED Inc | INSM | 2026-08-06 | 8-K | topline | false | ef20079469_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1104506/000114036126031502/ef20079469_ex99-2.htm |
0001140361-26-031502 | 1104506 | INSMED Inc | INSM | 2026-08-06 | 8-K | ind | false | ef20079469_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1104506/000114036126031502/ef20079469_ex99-2.htm |
0001159036-26-000103 | 1159036 | HALOZYME THERAPEUTICS, INC. | HALO | 2026-08-06 | 8-K | topline | false | ex991q220268-k.htm | https://www.sec.gov/Archives/edgar/data/1159036/000115903626000103/ex991q220268-k.htm |
0001140361-26-031671 | 1444192 | Grace Therapeutics, Inc. | GRCE | 2026-08-06 | 8-K | crl | true | ef20079559_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1444192/000114036126031671/ef20079559_ex99-1.htm |
0001140361-26-031671 | 1444192 | Grace Therapeutics, Inc. | GRCE | 2026-08-06 | 8-K | clinical_hold | true | ef20079559_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1444192/000114036126031671/ef20079559_ex10-1.htm |
0001140361-26-031671 | 1444192 | Grace Therapeutics, Inc. | GRCE | 2026-08-06 | 8-K | orphan | false | ef20079559_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1444192/000114036126031671/ef20079559_ex99-1.htm |
0001193125-26-336462 | 2100782 | Generate Biomedicines, Inc. | GENB | 2026-08-06 | 8-K | fast_track | false | ck0002100782-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2100782/000119312526336462/ck0002100782-ex99_1.htm |
0001193125-26-337964 | 2044725 | Evommune, Inc. | EVMN | 2026-08-06 | 8-K | topline | false | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526337964/evmn-ex99_1.htm |
0001193125-26-337964 | 2044725 | Evommune, Inc. | EVMN | 2026-08-06 | 8-K | endpoint_missed | true | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526337964/evmn-ex99_1.htm |
0001193125-26-337964 | 2044725 | Evommune, Inc. | EVMN | 2026-08-06 | 8-K | discontinue | true | evmn-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/2044725/000119312526337964/evmn-ex99_1.htm |
0001493152-26-036326 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-06 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226036326/ex99-1.htm |
0001493152-26-036268 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-06 | 8-K | topline | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226036268/ex99-1.htm |
0001493152-26-036268 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-06 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226036268/ex10-1.htm |
0001493152-26-036326 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-06 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226036326/ex99-1.htm |
0001493152-26-036268 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-08-06 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226036268/ex99-1.htm |
0001104659-26-091671 | 1710072 | Edgewise Therapeutics, Inc. | EWTX | 2026-08-06 | 8-K | topline | false | tm2621653d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1710072/000110465926091671/tm2621653d1_ex99-1.htm |
0001714899-26-000096 | 1714899 | Denali Therapeutics Inc. | DNLI | 2026-08-06 | 8-K | orphan | false | ex991pressreleaseq22026.htm | https://www.sec.gov/Archives/edgar/data/1714899/000171489926000096/ex991pressreleaseq22026.htm |
0001193125-26-338006 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-08-06 | 8-K | topline | false | dftx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000119312526338006/dftx-ex99_1.htm |
0001193125-26-338006 | 1813814 | Definium Therapeutics, Inc. | DFTX | 2026-08-06 | 8-K | endpoint_met | false | dftx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1813814/000119312526338006/dftx-ex99_1.htm |
0001193125-26-336700 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-08-06 | 8-K | topline | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526336700/cgem-ex99_1.htm |
0001193125-26-336700 | 1789972 | Cullinan Therapeutics, Inc. | CGEM | 2026-08-06 | 8-K | pdufa | false | cgem-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1789972/000119312526336700/cgem-ex99_1.htm |
0001171843-26-005317 | 1626971 | Corvus Pharmaceuticals, Inc. | CRVS | 2026-08-06 | 8-K | fast_track | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/1626971/000117184326005317/exh_991.htm |
0001171843-26-005317 | 1626971 | Corvus Pharmaceuticals, Inc. | CRVS | 2026-08-06 | 8-K | orphan | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/1626971/000117184326005317/exh_991.htm |
0001193125-26-336864 | 1595097 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 2026-08-06 | 8-K | topline | false | crbp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1595097/000119312526336864/crbp-ex99_1.htm |
0001193125-26-336762 | 1768446 | Climb Bio, Inc. | CLYM | 2026-08-06 | 8-K | topline | false | clym-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1768446/000119312526336762/clym-ex99_1.htm |
0001193125-26-336762 | 1768446 | Climb Bio, Inc. | CLYM | 2026-08-06 | 8-K | fast_track | false | clym-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1768446/000119312526336762/clym-ex99_1.htm |
0001193125-26-336762 | 1768446 | Climb Bio, Inc. | CLYM | 2026-08-06 | 8-K | orphan | false | clym-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1768446/000119312526336762/clym-ex99_1.htm |
0001171843-26-005316 | 744218 | Celldex Therapeutics, Inc. | CLDX | 2026-08-06 | 8-K | topline | false | exh_991.htm | https://www.sec.gov/Archives/edgar/data/744218/000117184326005316/exh_991.htm |
0001453687-26-000100 | 1453687 | Cartesian Therapeutics, Inc. | RNAC | 2026-08-06 | 8-K | orphan | false | exhibit991_earningsrelease.htm | https://www.sec.gov/Archives/edgar/data/1453687/000145368726000100/exhibit991_earningsrelease.htm |
0001193125-26-338021 | 1061983 | CYTOKINETICS INC | CYTK | 2026-08-06 | 8-K | topline | false | cytk-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1061983/000119312526338021/cytk-ex99_1.htm |
0001193125-26-336886 | 1991792 | CG Oncology, Inc. | CGON | 2026-08-06 | 8-K | topline | false | ck0001991792-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1991792/000119312526336886/ck0001991792-ex99_1.htm |
0001628280-26-053940 | 1828185 | Barinthus Biotherapeutics plc. | BRNS | 2026-08-06 | 8-K | topline | false | brns-20260630xexx991.htm | https://www.sec.gov/Archives/edgar/data/1828185/000162828026053940/brns-20260630xexx991.htm |
0001520138-26-000312 | 1580149 | BIOVIE INC. | null | 2026-08-06 | 8-K | topline | false | bivi-20260806_8kex99z1.htm | https://www.sec.gov/Archives/edgar/data/1580149/000152013826000312/bivi-20260806_8kex99z1.htm |
0001048477-26-000015 | 1048477 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2026-08-06 | 8-K | endpoint_met | false | earningsrelease-6aug26ex991.htm | https://www.sec.gov/Archives/edgar/data/1048477/000104847726000015/earningsrelease-6aug26ex991.htm |
0001048477-26-000015 | 1048477 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2026-08-06 | 8-K | pdufa | false | earningsrelease-6aug26ex991.htm | https://www.sec.gov/Archives/edgar/data/1048477/000104847726000015/earningsrelease-6aug26ex991.htm |
0001048477-26-000015 | 1048477 | BIOMARIN PHARMACEUTICAL INC | BMRN | 2026-08-06 | 8-K | discontinue | true | earningsrelease-6aug26ex991.htm | https://www.sec.gov/Archives/edgar/data/1048477/000104847726000015/earningsrelease-6aug26ex991.htm |
0001193125-26-337986 | 1817241 | Artiva Biotherapeutics, Inc. | ARTV | 2026-08-06 | 8-K | topline | false | artv-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1817241/000119312526337986/artv-ex99_1.htm |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.